US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Gene Editing

441.41

-3.1831-0.72%

Number of Gainers:1

Number of Losers:3

Number of Flat:- -

PE:- -

High:454.21

Open:446.88

Low:440.69

Close:444.59

Volume:9.67M

Turnover:171.93M

Market Cap:9.96B

Float Cap:9.35B

Loading ...

ToolGen Raises KRW 19.5 Billion to Fund CRISPR Patent Battles and R&D

Snowflake, Palo Alto, Dell, GameStop, Crispr Insider Shock

Crispr Therapeutics General Counsel James R. Kasinger Disposes of Common Shares Worth $626,459.6

Editas slips amid pressure on gene-editing sector after Anthropic update

Claude discovers novel enzyme system with CRISPR-like repeats

Editas Medicine Raised to Buy from Neutral by Guggenheim

Guggenheim Upgrades Editas Medicine to Buy From Neutral, Price Target is $5

MT Newswires Live

Cathie Wood’s ARK Investment buys 103K shares of Beam Therapeutics today

Crispr Therapeutics Director Ali Behbahani Disposes of Common Shares Worth $780,649.24

Danaher’s IDT, Aldevron launch research grade S.p. Cas9 mRNA, SpyFi

Top Premarket Gainers

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/BK4556/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4556","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4556\",,,,,undefined,":{"symbol":"BK4556","market":"US","secType":"PLATE","nameCN":"Gene Editing","latestPrice":441.4069,"timestamp":1790798399999,"preClose":444.59003,"halted":0,"volume":9667997,"delay":0,"changeRate":-0.00716,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-3.183136,"latestTime":"09-30 16:00:00 EDT","open":446.8802,"high":454.21283,"low":440.69354,"amount":171927314.449795,"amplitude":0.030408,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1790812800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":2.642471,"peRate":-9.52669,"turnoverRate":0.022107,"increases":1,"decrements":3,"flats":0,"marketCap":9956027904,"floatMarketCap":9348233760},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4556\",,,,,undefined,":{"symbol":"BK4556","high":454.21283,"amplitude":0.030408,"preClose":444.59003,"low":440.69354,"pbRate":"2.642471","latestPrice":441.4069,"volume":9667997,"delay":0,"open":446.8802,"prevYearClose":431.70972,"prevWeekClose":433.9813,"prevMonthClose":478.4385,"prevQuarterClose":517.3469,"fiveDayClose":445.2845,"twentyDayClose":475.6278,"sixtyDayClose":567.181,"secType":"PLATE","market":"US","turnoverRate":0.022107,"peRate":-9.52669,"marketCap":9956027904,"floatMarketCap":9348233760,"timestamp":1790798399999,"nameCN":"Gene Editing"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4556\",,,,undefined,":{"bkCode":"BK4556","up":1,"down":3,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4556\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2670484284","title":"ToolGen Raises KRW 19.5 Billion to Fund CRISPR Patent Battles and R&D","url":"https://stock-news.laohu8.com/highlight/detail?id=2670484284","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670484284?lang=en_us&edition=fundamental","pubTime":"2026-09-28 15:14","pubTimestamp":1790579642,"startTime":"0","endTime":"0","summary":"ToolGen Incorporated ( ($KR:199800) ) has shared an update. ToolGen has completed a KRW 19.46 billion paid-in capital increase via a rights offerin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/toolgen-raises-krw-19-5-billion-to-fund-crispr-patent-battles-and-rd?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/toolgen-raises-krw-19-5-billion-to-fund-crispr-patent-battles-and-rd?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARKG","BK4611","BK4585","LU1861559042.SGD","BK4588","CRSP","SYNB","LU1861558580.USD","BK4139","BK4556"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670471230","title":"Snowflake, Palo Alto, Dell, GameStop, Crispr Insider Shock","url":"https://stock-news.laohu8.com/highlight/detail?id=2670471230","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670471230?lang=en_us&edition=fundamental","pubTime":"2026-09-26 21:00","pubTimestamp":1790427654,"startTime":"0","endTime":"0","summary":"Insiders have been trading these 5 stocks: (($SNOW)), (($PANW)), (($DELL)), (($GME)) and (($CRSP)). Here is a breakdown of their recent trades and ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/snowflake-palo-alto-dell-gamestop-crispr-insider-shock?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/snowflake-palo-alto-dell-gamestop-crispr-insider-shock?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BUG","LU2023250504.SGD","PALD","LU2065171402.SGD","LU0345770993.USD","GME","CLOU","LU1267930227.SGD","LU2125909916.SGD","IHAK","LU2322448791.USD","LU2360107168.USD","LU1169589451.USD","LU2023250843.SGD","LU0128525689.USD","LU0823421333.USD","LU2272731865.HKD","LU0082616367.USD","LU0348723411.USD","DAT","WISE","LU1548497426.USD","LU0234570918.USD","LU0097036916.USD","LU2290526834.HKD","LU1951198990.SGD","LU1861559042.SGD","LU0109392836.USD","PALU","LU0719512351.SGD","LU1235294995.USD","BK4551","LU0823434740.USD","BK4556","SNOU","BK4547","BK4577","LU2355687059.USD","LU2357305700.SGD","ARKG","LU1046421795.USD","GMEC","LU1989764664.SGD","LU2322448957.HKD","LU1623119135.USD","LU2272731782.SGD","BK4613","IE00BMPRXN33.USD","FXL","LU0266013472.USD","SNOY","LU1720051108.HKD","LU0823421416.USD","LU2065170008.USD","DELL","LU2065171311.SGD","XDAT","GMEU","IE00BZ1G4Q59.USD","LU0081259029.USD","IE00BKVL7J92.USD","BK4505","BK4585","LU1803068979.SGD","BK4170","WCLD","LU0496365809.HKD","LU1861220033.SGD","SNOW","HAKY","LU0211326839.USD","PANW","LU1951200564.SGD","LU1989764748.USD","BK4548","CLOD","LU1974910355.USD","SPAM","BK4611","LU1917777945.USD","LU2272731600.USD","BK4097","LU0889565833.HKD","LU0267386448.USD","LU1861558580.USD","BK4554","LU2210149790.SGD","BK4560","LU1923623000.USD","BK4116","IGV","LU0345770308.USD","LU2095319765.USD","LU0211326755.USD","BK4607","BK4076","BK4543","IE00B19Z9505.USD","LU1861215975.USD","BK4535","LU1992135472.HKD","BK4503","LU2210150020.SGD","IE00B19Z8X17.USD","LU1823568750.SGD","BK4139","LU2286300806.USD","BK4588","LU1804176565.USD","IGME","BK4598","LU2473716301.USD","LU2265009873.SGD","BK4532","IE00BMPRXR70.SGD","CIBR","PSWD","LU0310800965.SGD","BK4559","LU1923622291.USD","PANG","LU2106854487.HKD","LU1169590202.USD","LU2125909759.SGD","LU2250418816.HKD","SG9999001424.SGD","LU2360106780.USD","LU1720051017.SGD","LU0976567544.SGD","LU2065169927.USD","DLLL","IE00B19Z8W00.USD","GMEY","LU1992135399.USD","LU0056508442.USD","LU0052756011.USD","CRSP","LU1712237335.SGD","WLDR","BK4515","AIFD","BK4550","BK4581","LU1852331112.SGD","WCBR","LU0823434583.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670413710","title":"Crispr Therapeutics General Counsel James R. Kasinger Disposes of Common Shares Worth $626,459.6","url":"https://stock-news.laohu8.com/highlight/detail?id=2670413710","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670413710?lang=en_us&edition=fundamental","pubTime":"2026-09-25 05:35","pubTimestamp":1790285746,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics General Counsel James R. Kasinger disposes of common shares worth $626,459.6James R. Kasinger, general counsel and secretary, sold 10,400 common shares on Sept. 22 at USD 60.2365.T","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDL3lyBzR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Crispr Therapeutics General Counsel James R. Kasinger Disposes of Common Shares Worth $626,459.6","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4139","BK4588","CRSP","BK4556","LU1861559042.SGD","LU1861558580.USD","ARKG","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669435367","title":"Editas slips amid pressure on gene-editing sector after Anthropic update","url":"https://stock-news.laohu8.com/highlight/detail?id=2669435367","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669435367?lang=en_us&edition=fundamental","pubTime":"2026-09-24 02:55","pubTimestamp":1790189712,"startTime":"0","endTime":"0","summary":"Editas Medicine (EDIT) is trading lower alongside other gene editing peers after Anthropic shared early findings on a CRISPR like enzyme system. An...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/editas-slips-amid-pressure-on-gene-editing-sector-after-anthropic-update-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/editas-slips-amid-pressure-on-gene-editing-sector-after-anthropic-update-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4611","BK4588","GNMX","BK4139","CRSP","LU1861558580.USD","IDNA","HELX","SYNB","BK4556","LU1861559042.SGD","ARKG","WDNA","EDIT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669433986","title":"Claude discovers novel enzyme system with CRISPR-like repeats","url":"https://stock-news.laohu8.com/highlight/detail?id=2669433986","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669433986?lang=en_us&edition=fundamental","pubTime":"2026-09-24 02:15","pubTimestamp":1790187313,"startTime":"0","endTime":"0","summary":"Anthropic is introducing a new life sciences research group and laboratory, with a focus on fundamental biology research using Claude – exploring d...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/claude-discovers-novel-enzyme-system-with-crispr-like-repeats-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/claude-discovers-novel-enzyme-system-with-crispr-like-repeats-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARKG","BK4588","BK4611","LU1861558580.USD","BK4585","BK4556","LU1861559042.SGD","SYNB","BK4139","CRSP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669048573","title":"Editas Medicine Raised to Buy from Neutral by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2669048573","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669048573?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:39","pubTimestamp":1790167140,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/EDIT/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EDIT","BK4139","BK4556"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669007891","title":"Guggenheim Upgrades Editas Medicine to Buy From Neutral, Price Target is $5","url":"https://stock-news.laohu8.com/highlight/detail?id=2669007891","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669007891?lang=en_us&edition=fundamental","pubTime":"2026-09-23 19:09","pubTimestamp":1790161752,"startTime":"0","endTime":"0","summary":"Editas Medicine (EDIT) has an average rating of overweight and mean price target of $4.88, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EDIT","BK4139","BK4556"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669911491","title":"Cathie Wood’s ARK Investment buys 103K shares of Beam Therapeutics  today","url":"https://stock-news.laohu8.com/highlight/detail?id=2669911491","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669911491?lang=en_us&edition=fundamental","pubTime":"2026-09-22 08:30","pubTimestamp":1790037011,"startTime":"0","endTime":"0","summary":"20:28 EDT Cathie Wood’s ARK Investment buys 103K shares of Beam Therapeutics (BEAM) today Published first on TheFly – the ultimate source for real-...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-103k-shares-of-beam-therapeutics-today-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-103k-shares-of-beam-therapeutics-today-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARKX","BK4588","BK4007","BEAM","ARKG","ARKW","BK4585","BK4505","ARKK","BK4539","BK4611","ARKQ","ARKF","LU1861558580.USD","BK4544","LENZ","SARK","BK4556","BK4139","LU1861559042.SGD","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669843196","title":"Crispr Therapeutics Director Ali Behbahani Disposes of Common Shares Worth $780,649.24","url":"https://stock-news.laohu8.com/highlight/detail?id=2669843196","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669843196?lang=en_us&edition=fundamental","pubTime":"2026-09-22 06:41","pubTimestamp":1790030476,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics director Ali Behbahani disposes of common shares worth $780,649.24CRISPR Therapeutics director Ali Behbahani exercised stock options for 30,000 common shares at USD 14 on Sept. 17,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDL112S6t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Crispr Therapeutics Director Ali Behbahani Disposes of Common Shares Worth $780,649.24","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU1861558580.USD","BK4588","BK4611","CRSP","BK4556","LU1861559042.SGD","ARKG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667983573","title":"Danaher’s IDT, Aldevron launch research grade S.p. Cas9 mRNA, SpyFi","url":"https://stock-news.laohu8.com/highlight/detail?id=2667983573","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667983573?lang=en_us&edition=fundamental","pubTime":"2026-09-16 20:15","pubTimestamp":1789560943,"startTime":"0","endTime":"0","summary":"Danaher (DHR) companies Integrated DNA Technologies, IDT, and Aldevron announced the launch of research grade S.p. Cas9 mRNA in wild type and SpyFi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/danahers-idt-aldevron-launch-research-grade-s-p-cas9-mrna-spyfi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/danahers-idt-aldevron-launch-research-grade-s-p-cas9-mrna-spyfi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4534","LU0312595415.SGD","LU0432979614.USD","LU0820562030.AUD","LU2063271972.USD","IE00BQXX3D17.EUR","LU0109391861.USD","LU1791710582.SGD","BK4139","LU2211814178.USD","LU2112291526.USD","LU1551013342.USD","BK4556","BK4504","LU0511384066.AUD","LU0708995401.HKD","LU0820561818.USD","IE00BKVL7J92.USD","IE00BQXX3F31.USD","LU0114720955.EUR","DHR","LU0528227936.USD","LU0820561909.HKD","LU1923621640.USD","SGXZ57979304.SGD","BK4581","LU2125909247.SGD","ARKG","LU0689472784.USD","BK4611","LU0672654240.SGD","LU1974910355.USD","SG9999004303.SGD","FMED","IE00BZ1G4Q59.USD","LU0289961442.SGD","LU1551013425.SGD","LU2125910179.SGD","BK4121","LU0289960550.SGD","LU0390134368.USD","LU1791710400.SGD","LU1923622614.USD","BK4533","LU2106854487.HKD","LU1917777945.USD","LU0097036916.USD","CRSP","LU0107464264.USD","LU2125909593.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667641500","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2667641500","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667641500?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:12","pubTimestamp":1789470776,"startTime":"0","endTime":"0","summary":"Advasa  shares were up more than 49% in Tuesday's premarket activity, rebounding from a 58% loss in the previous session.Vera Therapeutics  stock was over 14% higher after the company said its kidney disease drug met all prespecified endpoints in a phase 3 trial final efficacy analysis.Radiant Logistics  shares were up 13% after the company reported higher fiscal Q4 adjusted earnings and revenue.Editas Medicine  stock was 9% higher after a 1.5% advance in the prior day's session.Eltek  shares were up 7%, extending Monday's 10% rise.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EDIT","BK4539","ELTK","ADBT","BK4148","BK4585","BK4556","RLGT","VERA","BK4131","LU2324357040.USD","BK4588","BK4139","BK4023"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":11,"code":"91000000","status":"200"}]}}